Opportunity Radar

← Back to search

Grant forecast

Critical Path Public Private Partnerships Clinical Trials Optional

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
CA,G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
FOR-FD-24-012
Posted
Nov 30, 2023
CFDA / Assistance listing
93.103
Award floor
$20,000,000
Award ceiling
$20,000,000
Contact
Terrin Brown Grantor · terrin.brown@fda.hhs.gov · (240) 402-7610
Source
Grants.gov

Description

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act. This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.

Similar open opportunities